Sustainable and responsible operations
  • We are committed to building sustainability into our supply chain by ensuring our suppliers meet stringent standards for quality, reliability, and environmental and social responsibility. Our manufacturing processes prioritize consistency and ongoing improvements in environmental sustainability. We focus on reducing our carbon footprint, sorting and recycling waste, and optimizing resource usage. Additionally, we are committed to increasing the use of sustainable materials without compromising product quality. Through these efforts, we provide responsible, high-quality solutions that meet our customers' values and expectations. 
  • We are actively looking for more sustainable packaging materials to ship our products to our customers across the globe. For more information about our packaging material types, please contact  medix@medixbiochemica.com
Innovation
  • Medix Biochemica has been from its foundation a pioneer in sustainability as the company was one of the first to commercialize highly ethical and scalable in vitro, non-animal based, manufacturing of monoclonal antibodies at industrial scale in the 1990’s.  
  • Since then, we are dedicated to driving innovation by investing substantial part of annual sales into product development, focusing on adopting ever more sustainable technologies. This enables us to offer recombinant alternatives for antibodies and antigens, providing more responsible options for our customers. Our investment in these technologies not only broadens our product portfolio but also enhances supply chain efficiency and improves patient care.  
  • 20 percent of our personnel work in R&D. By working closely with scientific communities, we continuously advance diagnostic solutions, ensuring that our immunodiagnostics, quality control materials, and molecular diagnostics meet the highest standards of sustainability and quality. 

The overall framework for our sustainability goals stem from the United Nations 17 Sustainability Development Goals (SDGs): THE 17 GOALS | Sustainable Development (un.org) which call for action and support companies’ efforts to achieve more sustainable future for everyone. Among these SDG’s, Medix Biochemica can contribute the most to the following ones:

Sustainability assessments

EcoVadis

We are pleased to continue our sustainability journey at Medix Biochemica. Medix Biochemica joined EcoVadis sustainability rating system in 2023 and scored Bronze Medal with the first response, outscoring 72% of all companies rated by the system. In 2024 we improved our sustainability performance and earned Silver Medal, outscoring 89% of all companies rated by EcoVadis. 

The rating validates and demonstrates our commitment to sustainability and most importantly, it shows us where we can improve. Over the past few years, we have further increased our focus on corporate social responsibility and efforts on environmental responsibility. 

 

 

Responsible Care

Responsible Care logo

Medix Biochemica has been a member of the Responsible Care® program for Chemical Industry in Finland since 2017 and reported sustainability metrics since 2016. To prepare for CSRD, the new Corporate Sustainability Reporting Directive, Medix Biochemica has counted scope 1, 2 and 3 carbon emissions, and published the first data from 2023 on the website, well in advance of the required timelines.